CSI Market
Sign In | Register

Shuttle Pharmaceuticals Holdings Inc (SHPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SHPH Annual Cash Flow →
Quarterly cash flow trends provide additional context on Shuttle Pharmaceuticals Holdings Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-2.15
Depreciation & amortization0.63
Amortization of Other Assets0.01
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.04
Income (Loss) from Equity Method Investments0.00
Fair Value of Assets Acquired0.00
Operating Lease Right Of Use Asset Amortization Expense-
Gain Loss Related To Litigation Settlement-
Debt Securities Gain Loss-
Change In Fair Value Of Derivative Liability-
Marketable Securities Unrealized Gain Loss-
Accrued Interest Settled With Common Stock-
Loss On Settlement Of Convertible Debt-
Gain On Forgiveness Of Note Payable-
Increase Decrease In Accrued Interest Payable Related Parties-
Marketable Securities Gain Loss-
Expense For Debt Issuance Costs Due To Fair Value Election On Convertible Notes-
Expense For Issuance Costs Due To Liability Classified Warrants-
Loss On Issuance Of Convertible Notes Fair Value Option-
Derivative Gain Loss On Derivative Net-0.08
Change In Fair Value Of Convertible Notes-
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accrued Interest Receivable, Net0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.34
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.20
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-2.42
Investing Activities
Capital Expenditures-0.04
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.21
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock And Exercise Of Warrants-
Proceeds From Notes Payable And Warrants-
Payment For Issuance Costs-
Proceeds From Repayment Of Warrant Exercises-
Payments Of Convertible Financing Costs-
Proceeds From Issuance Of Common Stock One-
Payment For Issuance Costs Related To Liabilityclassified Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.21
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.45
Total Cash Flow0.76
4 historic quarters locked

Sign in to unlock the full Shuttle Pharmaceuticals Holdings Inc cash flow history.

Sign In Create Free Account

About Shuttle Pharmaceuticals Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260331)
  • Filed with the SEC: May 15, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-023859

Figures are derived from filed reports and may be restated. Historical data is subject to revision.